Search research articles
Contact Us
Filters
Showing results (71-80 of 567) with videos related to
Page
of 57
Sort By:
Molecular Cancer Therapeutics
|
September 17, 2009
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells
Young-Kwang Yoon, Hwang-Phill Kim, Sae-Won Han, et al.
Cancer Letters
|
November 16, 2011
Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells
Young-Kwang Yoon, Hwang-Phill Kim, Sang-Hyun Song, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 10, 2005
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
Do-Youn Oh, Jee-Hyun Kim, Dong-Wan Kim, et al.
International Journal of Cancer
|
March 27, 2023
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial
Elżbieta Senkus, Suzette Delaloge, Susan M Domchek, et al.
Nutrition and Cancer
|
June 11, 2016
Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy
Dae-Won Lee, Kyung-Hun Lee, Tae-Yong Kim, et al.
Breast Cancer Research and Treatment
|
August 30, 2020
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
Ji-Yeon Kim, Kyunghee Park, Seock-Ah Im, et al.
BMC Cancer
|
December 19, 2008
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
Mi-Jung Kim, Do-Youn Oh, Se-Hoon Lee, et al.
Cancer Letters
|
February 14, 2013
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
Mi-Jung Kim, Hyun-Jin Nam, Hwang-Phill Kim, et al.
International Journal of Oncology
|
April 30, 2010
DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells
Heesun Kim, Jinah Park, Yeonjoo Jung, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 24, 2015
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications
Chan-Young Ock, Tae-Yong Kim, Kyung-Hun Lee, et al.
Page
of 57
Search research articles
Search
Showing results (71-80 of 567) with videos related to
Sort By:
Page
of 57
Molecular Cancer Therapeutics
|
September 17, 2009
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells
Young-Kwang Yoon, Hwang-Phill Kim, Sae-Won Han, et al.
Cancer Letters
|
November 16, 2011
Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells
Young-Kwang Yoon, Hwang-Phill Kim, Sang-Hyun Song, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 10, 2005
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
Do-Youn Oh, Jee-Hyun Kim, Dong-Wan Kim, et al.
International Journal of Cancer
|
March 27, 2023
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial
Elżbieta Senkus, Suzette Delaloge, Susan M Domchek, et al.
Nutrition and Cancer
|
June 11, 2016
Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy
Dae-Won Lee, Kyung-Hun Lee, Tae-Yong Kim, et al.
Breast Cancer Research and Treatment
|
August 30, 2020
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
Ji-Yeon Kim, Kyunghee Park, Seock-Ah Im, et al.
BMC Cancer
|
December 19, 2008
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
Mi-Jung Kim, Do-Youn Oh, Se-Hoon Lee, et al.
Cancer Letters
|
February 14, 2013
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
Mi-Jung Kim, Hyun-Jin Nam, Hwang-Phill Kim, et al.
International Journal of Oncology
|
April 30, 2010
DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells
Heesun Kim, Jinah Park, Yeonjoo Jung, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 24, 2015
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications
Chan-Young Ock, Tae-Yong Kim, Kyung-Hun Lee, et al.
Page
of 57